Geriatrics News

High use of anticholinergic medications such as antihistamines and antidepressants may increase the risks for dementia and Alzheimer’s disease in the elderly, according to study results.

Researchers have developed a patient self-reporting monitor that resembles a blood pressure cuff to measure cognition, functional and psychological symptoms in a primary care setting, according to a press release.

Cerebrovascular disease is often associated with Alzheimer’s disease, and especially with cognitive decline, according to researchers.

A systematic review and meta-analysis of 25 randomized controlled trials yielded no significant association between statin therapy and cognitive impairment.

Patients may display symptoms of depression before the onset of Alzheimer’s disease symptoms, according to data published in Neurology.

A higher dose of intranasal insulin detemir improved cognition among patients with Alzheimer’s disease and mild cognitive impairment, with greater improvement among carriers of the APOE-e4 gene, according to pilot study data.

Irreversible vision loss had negative effects on patients’ quality of life and mental health, including greater levels of depression during adjustments, according to study data.

In 2014, Healio Psychiatry provided the latest developments in psychiatry and mental health research. The most-read articles summarized peer reviewed journal publications; allowing specialists to critically examine the relevant information they can apply in day-to-day practice.

Older Latino adults who believe their neighborhood has a low crime rate are less likely to have elevated symptoms of depression, according to data published in the Journal of Aging and Health.

The FDA approved the new drug application for Namzaric, a fixed-dose combination of memantine hydrochloride extended-release and donepezil hydrochloride, for the treatment of moderate-to-severe Alzheimer’s disease, according to an Actavis and Adamas Pharmaceuticals press release.